Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

FDA Safety Warning for Gilenya and PML, Rare Brain Disease

FDA Safety Warning for Gilenya and PML, Rare Brain Disease

August 29, 2013 — Gilenya, a medication for multiple sclerosis (MS), has been linked to one case of a rare but serious brain infection called progressive multifocal leukoencepalopathy (PML).

Novartis first reported the case in July. The U.S. Food and Drug Administration (FDA) has also issued a Drug Safety Communication.

According to the FDA:

“Patients should not stop taking Gilenya without first discussing any questions or concerns with their health care professionals. We are providing this alert while we continue to investigate the PML case.”

Novartis reported that the patient was treated with Gilenya for nearly eight months. Before using Gilenya, the patient took other medications, but not Tysabri (natalizumab), which is another MS drug that has been linked to PML. The patient was diagnosed based upon symptoms and discovery of the JC virus DNA in their cerebrospinal fluid.

This is the first case of PML associated with Gilenya. Novartis has reported that 71,000 people have used Gilenya to treat MS since it was approved in 2010.

What is PML?

Progressive Multifocal Leukoencephalopathy (PML) is a rare but serious brain infection that is caused by the John Cunningham (JC) virus. Although infection with the JC virus is widespread, it usually only causes PML in people with weak immune systems. Drugs that weaken a person’s immune system, such as Gilenya, may also increase the risk of PML.

PML damages myelin, which is a fatty covering around nerves in the brain and spinal cord that insulates electrical signals. Damage to myelin can cause electrical signals to slow down.

Symptoms and complications of PML:

  • Paralysis
  • Progressive weakness, clumsiness
  • Blindness, double vision, or decreased vision
  • Decreased ability to use a body part or limbs
  • Seizures
  • Speech problems (unable to understand or use language)
  • Fatigue
  • Loss of balance, falling
  • Confusion, disorientation

Do I have a Gilenya Lawsuit?

The Schmidt Firm, PLLC is currently accepting Gilenya induced injury cases in all 50 states. If you or somebody you know has been diagnosed with a severe side effect, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs’ law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm’s reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.

*
*
*